These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 5571452

  • 1. Oral contraceptives after liver disease.
    Eisalo A, Konttinen A, Hietala O.
    Br Med J; 1971 Sep 04; 3(5774):561-2. PubMed ID: 5571452
    [Abstract] [Full Text] [Related]

  • 2. Effect of oral contraceptives on the liver in women with recurrent cholestasis (hepatosis) during previous pregnancies.
    Rannevik G, Jeppsson S, Kullander S.
    J Obstet Gynaecol Br Commonw; 1972 Dec 04; 79(12):1128-36. PubMed ID: 4119034
    [No Abstract] [Full Text] [Related]

  • 3. Oral contraceptives and the liver.
    Metreau JM, Dhumeaux D, Berthelot P.
    Digestion; 1972 Dec 04; 7(5):318-35. PubMed ID: 4602326
    [No Abstract] [Full Text] [Related]

  • 4. Oral contraceptives in acute viral hepatitis.
    Schweitzer IL, Weiner JM, McPeak CM, Thursby MW.
    JAMA; 1975 Sep 01; 233(9):979-80. PubMed ID: 1173920
    [Abstract] [Full Text] [Related]

  • 5. [Oral contraceptives and the liver].
    de Pagter AG, van Berge Henegouwen GP, Brandt KH, Bronkhorst FB.
    Ned Tijdschr Geneeskd; 1979 May 26; 123(21):881-7. PubMed ID: 450151
    [Abstract] [Full Text] [Related]

  • 6. Serum enzyme activity and bromsulphalein retention during use of oral contraceptives.
    Wilbert L, Severidt E, Kallmann L, Hillmer T, Creutzfeldt W.
    Ger Med Mon; 1969 Sep 26; 14(9):451-4. PubMed ID: 5352297
    [No Abstract] [Full Text] [Related]

  • 7. Liver metabolism and contraceptive steroids.
    Brohult J, Westgren A.
    Lancet; 1965 Dec 25; 2(7426):1344. PubMed ID: 4165318
    [No Abstract] [Full Text] [Related]

  • 8. [Oral contraception and liver function].
    Starup J.
    Ugeskr Laeger; 1966 Jan 13; 128(2):41-3. PubMed ID: 5914779
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical adverse effects and biochemical changes due to ovulation inhibitors].
    Clavadetscher P, Weber H.
    Schweiz Med Wochenschr; 1973 Feb 17; 103(7):231-7. PubMed ID: 4686758
    [No Abstract] [Full Text] [Related]

  • 10. Functional and morphological liver changes in women taking oral contraceptives. A clinical and ultrastructural study with special reference to the occurrence of cholestasis.
    Pihl E, Rais O, Zeuchner E.
    Acta Chir Scand; 1968 Feb 17; 134(8):639-50. PubMed ID: 5713447
    [No Abstract] [Full Text] [Related]

  • 11. Investigations on the effect of an oral contraceptive and its components on liver function, serum proteins, copper, coeruloplasmin and gamma-glutamyl peptidase in postmenopausal women.
    Adlercreutz H, Eisalo A, Heino A, Luukkainen T, Penttilä I, Saukkonen H.
    Scand J Gastroenterol; 1968 Feb 17; 3(3):273-84. PubMed ID: 4179181
    [No Abstract] [Full Text] [Related]

  • 12. Liver function in Thai women using different types of hormonal contraceptive agents.
    Dusitsin N, Tankeyoon M, Larsson-Cohn U.
    J Med Assoc Thai; 1978 Jul 17; 61(7):381-9. PubMed ID: 681857
    [No Abstract] [Full Text] [Related]

  • 13. [Intrahepatic cholestasis of pregnancy (author's transl)].
    Krejs GJ, Blum AL.
    MMW Munch Med Wochenschr; 1974 Dec 20; 116(51-52):2237-42. PubMed ID: 4217430
    [No Abstract] [Full Text] [Related]

  • 14. [Serum enzyme activities and bromsulphalein retention due to ovulation inhibitors].
    Wilbert L, Severidt E, Kallmann L, Hillmer T, Creutzfeldt W.
    Dtsch Med Wochenschr; 1968 Nov 15; 93(46):2207-10. PubMed ID: 5683966
    [No Abstract] [Full Text] [Related]

  • 15. [Jaundice caused by oral contraceptives, pregnancy cholestasis and elevation of transaminases].
    Ancey P, Saint-Cyr M, Paliard P.
    Presse Med; 1989 Sep 30; 18(30):1480. PubMed ID: 2534176
    [No Abstract] [Full Text] [Related]

  • 16. Serum phosphohexose isomerase--its value in the differential diagnosis of jaundice.
    Cohn EM, Winsten S, Abramson EB.
    Am J Gastroenterol; 1969 Feb 30; 51(2):101-11. PubMed ID: 5776145
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical experiences with the 2-phase preparation Biogest Spofa for hormonal contraception].
    Flach W, Hamann B.
    Z Arztl Fortbild (Jena); 1977 Jan 01; 71(1):38-40. PubMed ID: 855375
    [No Abstract] [Full Text] [Related]

  • 18. [Serum transaminase excretion mechanism in rabbits].
    Ota H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1968 Dec 01; 20(12):1569-78. PubMed ID: 5752650
    [No Abstract] [Full Text] [Related]

  • 19. The effect of low-dose combined oral contraceptive pills versus injectable contraceptive (Depot Provera) on liver function tests of women with compensated bilharzial liver fibrosis.
    Tagy AH, Saker ME, Moussa AA, Kolgah A.
    Contraception; 2001 Sep 01; 64(3):173-6. PubMed ID: 11704097
    [Abstract] [Full Text] [Related]

  • 20. [Differential diagnosis of aminazine jaundice and viral hepatitis developing during aminazine treatment].
    Sinaĭko GA, Paktoris EA, Pozdniakova SL, Kutchak SN, Shumkina OB.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972 Jan 01; 72(1):112-7. PubMed ID: 5020147
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.